Posterior reversible encephalopathy syndrome after long-term treatment with low-dose sunitinib: a case report
Author:
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Neurology (clinical),Dermatology,General Medicine
Link
http://link.springer.com/article/10.1007/s10072-017-2851-7/fulltext.html
Reference5 articles.
1. Tari Capone F, Candela S, Bozzao F et al (2015) A new case of brainstem variant of posterior reversible encephalopathy syndrome: clinical and radiological features. Neurol Sci 36:1263–1265. doi: 10.1007/s10072-014-1999-7
2. Donmez FY, Agildere AM (2015) Recurrent childhood PRES. Neurol Sci 36:1603–1609. doi: 10.1007/s10072-015-2212-3
3. Fukui S, Toyoshima Y, Takeshi Inoue T et al (2016) Reversible posterior leukoencephalopathy syndrome developing after restart of sunitinib therapy for metastatic renal cell carcinoma. Case Rep Med 2016:6852951
4. Tlemsani C, Mir O, Boudou-Rouquette P et al (2011) Posterior reversible encephalopathy syndrome induced by anti-VEGF agents. Target Oncol 6:253–258
5. Izzedine H, Ederhy S, Goldwasser F et al (2009) Management of hypertension in angiogenesis inhibitor-treated patients. Ann Oncol 20:807–815
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Posterior reversible encephalopathy syndrome after anlotinib treatment for small cell lung cancer: A case report and literature review;Frontiers in Pharmacology;2023-02-06
2. Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Olfactory Neuroblastoma;Brain Sciences;2022-12-23
3. Neurologic complications of oncologic therapy;Handbook of Neuro-Oncology Neuroimaging;2022
4. Rare anti-VEGFR therapy-induced toxicity and long-term response to immunotherapy in a rare non-clear cell renal cell carcinoma patient;Anti-Cancer Drugs;2021-07-12
5. Posterior Reversible Encephalopathy Syndrome Associated With Anlotinib: A Case Report and Literature Review;Frontiers in Neurology;2021-05-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3